CCL7 and lung carcinoma: Taken together, Mar‐C promotes cell senescence with limited cytotoxicity, which acts as a selective SASP modulator, and NF‐κB partly participates in the regulating of SASP, suggesting the promising agent of Mar‐C for lung cancer treatment.81